• MUSC’s Opt-Out Approach To Recruitment Proves Popular With Patients

    Mar 23 | Clinical Research News | Consumers are by now accustomed to opting out of everything from unwanted telemarketing calls to text messages about a flash sale at their favorite department store. It is perhaps unsurprising then that they would not object to the idea of an opt-out approach to cold contact about a clinical trial for which they are potentially eligible. More

  • Gender Parity Still A Stretch Goal For Global Trials

    Mar 15 | Clinical Research News | Two different perspectives on the participation of women in clinical trials arise when looking at the situation locally and internationally. At the ground level in the U.S., at least on protocols that don’t exclude them, women often outnumber men by a wide margin even if all socioeconomic subgroups aren’t represented. On the other hand, females account for only about 31% of study participants across all 450,000 ongoing global trials. More

  • Community Pharmacists Can Help Sponsors Meet Trial Diversity Requirements

    Mar 14 | Clinical Research News | Independent, community-based pharmacists are in an ideal position to improve the equitable representation of racial and ethnic groups in clinical research, as required under the recently enacted 2023 omnibus spending bill. How to accomplish this is spelled out in a white paper, termed the Diversity Now protocol, newly published by the company that focuses on improving the recruitment and retention of underrepresented populations. More

  • ‘Circle Of Trust’ Model For Recruiting Indigenous Populations Into Trials

    Mar 09 | Clinical Research News | An existing trust-based intervention known to increase minority participation in clinical trials won’t do much to improve the representation of American Indians (AI) and Alaska Natives (AN) in studies, according to Arch G. Mainous III, Ph.D., professor in the department of community health and family medicine as well as health services research, management and policy at the University of Florida. Community engagement is critical when dealing with indigenous populations from a particular tribe or reservation. More

  • Jill Pellegrino of CVS Health Clinical Trial Services on Using RWE to Improve Clinical Trial Efficiency and Applicability

    Mar 07 | Clinical Research News | In 2020, retail pharmacy giant CVS launched CVS Health Clinical Trial Services to increase patient recruitment efforts and encourage equitable participation. In the latest Scope of Things podcast episode, Jill Pellegrino, vice president of recruitment and RWE at CVS Health Clinical Trial Services, speaks with host Deborah Borfitz about the company’s extensive clinical trial offerings. More

  • Tackling the Logistical Challenges of DCTS: Joined Up Services and Owning the Process

    Mar 03 | Clinical Research News | When hybrid and decentralized clinical trials rely on a patchwork of different suppliers, vendors, and couriers, logistics become a substantial administrative burden for sponsors and sites alike. That’s why an integrated project management approach to home health and distribution is vital. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More